All AbMole products are for research use only, cannot be used for human consumption.
For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.
PROTAC BRD9-binding moiety 1 hydrochloride is a compound that binds to BRD9, and used for inhibiting BRD9 activity, based on PROTAC.
| Molecular Weight | 556.05 |
| Formula | C23H26ClN3O7S2 |
| CAS Number | 2448414-41-1 |
| Form | Solid |
| Solubility (25°C) | DMSO 20 mg/mL Water 2.5 mg/mL |
| Storage | 4°C, dry, sealed |
| Related Ligands for Target Protein for PROTAC Products |
|---|
| BTK ligand 1
BTK ligand 1 is a ligand targeting Bruton’s tyrosine kinase (Btk). |
| TSPO ligand-1
TSPO ligand-1 is the ligand of AUTAC4 that can be used in the synthesis of PROTACs. |
| PROTAC PTK6 ligand-1
PROTAC PTK6 ligand-1 is an intermediate for BTK kinase inhibitor preparation. |
| PROTAC BRD4 ligand-2
PROTAC BRD4 ligand-2 is a ligand for target BRD4 protein for PROTAC CFT-2718. |
| Abemaciclib metabolite M18
Abemaciclib metabolite M18 (LSN3106729), the metabolite of Abemaciclib, is a CDK inhibitor with antitumor activity. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
